Tissue-specific genetic control of splicing: implications for the study of complex traits - PubMed (original) (raw)
Tissue-specific genetic control of splicing: implications for the study of complex traits
Erin L Heinzen et al. PLoS Biol. 2008.
Abstract
Numerous genome-wide screens for polymorphisms that influence gene expression have provided key insights into the genetic control of transcription. Despite this work, the relevance of specific polymorphisms to in vivo expression and splicing remains unclear. We carried out the first genome-wide screen, to our knowledge, for SNPs that associate with alternative splicing and gene expression in human primary cells, evaluating 93 autopsy-collected cortical brain tissue samples with no defined neuropsychiatric condition and 80 peripheral blood mononucleated cell samples collected from living healthy donors. We identified 23 high confidence associations with total expression and 80 with alternative splicing as reflected by expression levels of specific exons. Fewer than 50% of the implicated SNPs however show effects in both tissue types, reflecting strong evidence for distinct genetic control of splicing and expression in the two tissue types. The data generated here also suggest the possibility that splicing effects may be responsible for up to 13 out of 84 reported genome-wide significant associations with human traits. These results emphasize the importance of establishing a database of polymorphisms affecting splicing and expression in primary tissue types and suggest that splicing effects may be of more phenotypic significance than overall gene expression changes.
Conflict of interest statement
Competing interests. The authors have declared that no competing interests exist.
Figures
Figure 1. Idealized Representation of How Overall Expression and Alternative Splicing Events Are Reflected in the Exon Array Data
Top panel: In this study, all exon-level data were normalized across all exons and individuals. Transcript-level expression was reported for each transcript interrogated on the array by averaging (PLIER method) exon expression levels for all exons contained in a transcript (annotation details can be found at
). Subject 1 in this example has a higher overall transcript expression level (indicated by green line representing an average of exons A–G within subject 1) compared to subject 2 (red line). In this example, all exons contained in the transcript were expressed at approximately equal levels, suggesting that this transcript does not have alternative splice variants in either subject. Middle panel: An example of the detection of alternative splicing in which multiple transcripts are produced from a single gene through unique combination of the coding regions. Exon D in subject 2 appears to be expressed at lower quantities when compared to the other exons in the transcript (exon D expression levels lie below the average transcript line), indicating that this exon may be spliced out of the transcript in this subject (i.e., higher expression of transcript isoform II). Bottom panel: A scenario where we cannot definitively establish the combinatorial assembly of exons using these data. In this example, subject 2 has lower expression of both exons B and D. We cannot conclude that this subject has a higher proportion of transcript IV expressed compared to subject 1 or if transcript II and III are expressed at higher levels. Despite this shortcoming in situations of large heterogeneity of transcript isoforms produced with multiple alternative splicing events, these data provide a clear indicator of alternative exon composition within transcripts for a given individual. This study was specifically focused on the _cis_-acting genetic regulation of overall expression and splicing. Therefore, we were interested in identifying groups of splicing and expression patterns unique to individuals with the same genotype at certain commonly variant loci in and surrounding the transcript or exon. In cases where the expression of multiple exons was under genetic regulation, we declared it a splicing event if <40% of all exons contained in the transcript were associated with high confidence with the genotype. If >40% of exons were implicated, this was considered to be an overall expression change.
Figure 2. Principal Components Analysis of All Exon Expression Level Data for Both Brain and PBMC Samples
The differentiated pattern of expression suggests the need for tissue specific evaluations of alternative splicing and expression and demonstrates the added benefit of studying genetic regulation of splicing and expression in two unique and important cellular populations. A similar profile was observed for the transcript level expression values in the two tissue types suggesting the same level of tissue specificity for splicing.
Figure 3. Quantitative Real-Time PCR Confirmation of Selected Genetically Regulated Exon-Level Expression Changes in the Two Tissue Types
Three representative scenarios are presented. The top panel shows an sQTL that was present in both brain and PBMCs. The middle panel and bottom panel show sQTLs unique to a particular tissue type, providing unequivocal evidence for tissue specific genetic regulation.
Figure 4. Methodological Details Evaluating the Proximity of a Detected sQTL and Its Region of LD to a Splicing Regulatory Region
Red box represents an exon whose expression is correlated with the SNP indicated by the starred red bar. All SNPs in LD with this sQTL are shown by red bars and the height of the bar indicates the level of correlation (r 2) with the starred SNP. We assessed how often the range of LD for a given sQTL (defined by r 2 > 0.2 with the sQTL) extended into or surpassed the splicing regulatory region. This analysis was performed by evaluating all mRNA transcripts containing the exon regulated by the sQTL. The splicing regulatory region was defined as the genomic region from the start of the exon located upstream of the associated exon through the stop site of the downstream exon interrogated. If the exon was part of multiple transcripts the region including the most distal and proximal neighboring exons was defined the splicing regulatory region. If the affected exon was located at the beginning or end of the transcript then the range was truncated at the start or stop of the transcript, respectively. Finally, if a single SNP associated with more than one exon in a single transcript they were considered as a single entry in this analysis (i.e., sQTL LD needed only come in close proximity of one of the affected exons to be counted as a positive entry).
Figure 5. SNPExpress Database
Top panel: Output showing an example of an association between rs10876864 and a splicing change in RPS26. Software permits the input of an SNP, a gene, or a genomic region for comprehensive interrogation of associations between SNPs and exon/transcript expression levels in the regions surrounding the SNP. The blue frame indicates the SNPs genotyped on the chip, the two lighter blue frames correspond to the −log _p_-values for the brain and PBMC samples, the turquoise panel contains all Ensembl transcripts, and the bottom green panel shows all of the exons/transcripts screened for on the array. Bottom panel: This database can be applied in a SNP-centric or gene-centric approach for determining the functional and phenotypic consequences of genetic variation on the transcriptome.
Similar articles
- Genome-wide identification of splicing QTLs in the human brain and their enrichment among schizophrenia-associated loci.
Takata A, Matsumoto N, Kato T. Takata A, et al. Nat Commun. 2017 Feb 27;8:14519. doi: 10.1038/ncomms14519. Nat Commun. 2017. PMID: 28240266 Free PMC article. - Genome-wide survey of allele-specific splicing in humans.
Nembaware V, Lupindo B, Schouest K, Spillane C, Scheffler K, Seoighe C. Nembaware V, et al. BMC Genomics. 2008 Jun 2;9:265. doi: 10.1186/1471-2164-9-265. BMC Genomics. 2008. PMID: 18518984 Free PMC article. - Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs.
Pan Y, Liu H, Wang Y, Kang X, Liu Z, Owzar K, Han Y, Su L, Wei Y, Hung RJ, Brhane Y, McLaughlin J, Brennan P, Bickeböller H, Rosenberger A, Houlston RS, Caporaso N, Teresa Landi M, Heinrich J, Risch A, Wu X, Ye Y, Christiani DC, Amos CI, Wei Q. Pan Y, et al. Sci Rep. 2017 Mar 17;7:44634. doi: 10.1038/srep44634. Sci Rep. 2017. PMID: 28304396 Free PMC article. - Regional Variation of Splicing QTLs in Human Brain.
Zhang Y, Yang HT, Kadash-Edmondson K, Pan Y, Pan Z, Davidson BL, Xing Y. Zhang Y, et al. Am J Hum Genet. 2020 Aug 6;107(2):196-210. doi: 10.1016/j.ajhg.2020.06.002. Epub 2020 Jun 25. Am J Hum Genet. 2020. PMID: 32589925 Free PMC article. - The contribution of alternative splicing to genetic risk for psychiatric disorders.
Reble E, Dineen A, Barr CL. Reble E, et al. Genes Brain Behav. 2018 Mar;17(3):e12430. doi: 10.1111/gbb.12430. Epub 2017 Dec 6. Genes Brain Behav. 2018. PMID: 29052934 Review.
Cited by
- Examination of a novel expression-based gene-SNP annotation strategy to identify tissue-specific contributions to heritability in multiple traits.
Mize TJ, Evans LM. Mize TJ, et al. Eur J Hum Genet. 2024 Mar;32(3):263-269. doi: 10.1038/s41431-022-01244-1. Epub 2022 Nov 29. Eur J Hum Genet. 2024. PMID: 36446896 - Interpretation of the role of germline and somatic non-coding mutations in cancer: expression and chromatin conformation informed analysis.
Pudjihartono M, Perry JK, Print C, O'Sullivan JM, Schierding W. Pudjihartono M, et al. Clin Epigenetics. 2022 Sep 28;14(1):120. doi: 10.1186/s13148-022-01342-3. Clin Epigenetics. 2022. PMID: 36171609 Free PMC article. Review. - Transcriptional Regulation of RUNX1: An Informatics Analysis.
Thomas AL, Marsman J, Antony J, Schierding W, O'Sullivan JM, Horsfield JA. Thomas AL, et al. Genes (Basel). 2021 Jul 29;12(8):1175. doi: 10.3390/genes12081175. Genes (Basel). 2021. PMID: 34440349 Free PMC article. - Cholinergic receptor nicotinic beta 3 subunit polymorphisms and smoking in male Chinese patients with schizophrenia.
Shi J, Chen N, Wang Z, Wang F, Tan Y, Tan S, Tong J, An H, Guo X, Zuo L, Wang X, Yang F, Luo X. Shi J, et al. EC Psychol Psychiatr. 2021;10(7):11-23. Epub 2021 Jun 28. EC Psychol Psychiatr. 2021. PMID: 34368810 Free PMC article. - An Imperative Need for Further Genetic Studies of Alopecia Areata.
Petukhova L. Petukhova L. J Investig Dermatol Symp Proc. 2020 Nov;20(1):S22-S27. doi: 10.1016/j.jisp.2020.04.003. J Investig Dermatol Symp Proc. 2020. PMID: 33099379 Free PMC article. Review.
References
- Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, et al. A genome-wide association study of global gene expression. Nat Genet. 2007;39:1202–1207. - PubMed
- Kwan T, Benovoy D, Dias C, Gurd S, Provencher C, et al. Genome-wide analysis of transcript isoform variation in humans. Nat Genet. 2008;40:225–231. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources